Consensus Conference on Patient Specific Therapy

November 2, 2003
Hyatt Regency
Bethesda, MD

Robert K. Oldham, MD
Cancer Therapeutics, Thomasville, GA

Larry Kwak, MD, PhD
National Cancer Institute, Frederick, MD

Kenneth A. Foon, MD
University of Pittsburgh Cancer Institute, Pittsburgh, PA

11:00am	Pick Up Box Lunches
11:00-11:20am	Anti-Idiotypic Antibodies - Kenneth A. Foon, MD
11:20-11:40am	Idiotype Vaccines - Larry Kwak, MD, PhD
11:40am-12:00pm	T-cell Therapy - Mark Dudley, PhD
12:00-12:20pm	Dendritic Cell Therapy - Theresa Whiteside, PhD
12:20-12:40pm	Gene Modified Tumor Vaccines - Kristen Hege, MD
12:40-1:00pm	Autologous Tumor Vaccine Heat Shock Proteins - John Lewis, MD, PhD
1:00-1:20pm	Position talk from NCI - Howard Streicher, MD
1:20-1:40pm	Position talk from FDA - Raj Puri, MD, PhD
1:40-2:00pm	Position talk from Industry - Robert Oldham, MD
2:00-2:30pm	Break
2:30-4:30pm	Panel Discussion

Co-Chairs/Speakers:

Kenneth A. Foon, MD
University of Pittsburgh Cancer Institute
Pittsburgh, PA

Larry Kwak, MD, PhD
Nat'l Cancer Institute
Frederick, MD

Robert K. Oldham, MD
Univ. of Pittsburgh Cancer Institute
Thomasville, GA

Panelists:

Bob Bennett
CancerDrugsNow.Org
New York, NY

Michael Salgaller, PhD
Toucan Capital Corp.
Bethesda, MD

Speakers:

Mark Dudley, PhD
National Institutes of Health
Bethesda, MD

Kristen Hege, MD
Cell Genesys
South San Francisco, CA

Jonathan J. Lewis, MD, PhD
Antigenics, Inc.
New York, NY

Raj Puri, PhD
Food and Drug Administration
Bethesda, MD

Howard Streicher, MD
Cancer Therapy Evaluation Program
National Cancer Institute
Bethesda, MD

Theresa L. Whiteside, PhD
University of Pittsburgh Cancer Institute
Pittsburgh, PA

Consensus Conference on Patient Specific Therapy

Co-Chairs/Speakers:

Panelists:

Speakers:

Membership Links

Get Involved